These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32187231)
1. Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer. Bobbili P; Ryan K; DerSarkissian M; Dua A; Yee C; Duh MS; Gomez JE PLoS One; 2020; 15(3):e0230444. PubMed ID: 32187231 [TBL] [Abstract][Full Text] [Related]
2. Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants: A Phase 2 Randomized Clinical Trial. Bi N; Liang J; Zhou Z; Chen D; Fu Z; Yang X; Feng Q; Hui Z; Xiao Z; Lv J; Wang X; Zhang T; Wang X; Deng L; Wang W; Wang J; Liu L; Hu C; Wang L JAMA Netw Open; 2019 Dec; 2(12):e1918070. PubMed ID: 31851351 [TBL] [Abstract][Full Text] [Related]
3. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175 [TBL] [Abstract][Full Text] [Related]
4. Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter? Hendriks LEL; Brouns -JWM; Amini M; Uyterlinde W; Wijsman R; Bussink J; Biesma B; Oei SB; Stigt JA; Bootsma GP; Belderbos JSA; De Ruysscher DKM; Van den Heuvel MM; Dingemans AC Lung Cancer; 2016 Nov; 101():68-75. PubMed ID: 27794410 [TBL] [Abstract][Full Text] [Related]
5. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base. Sher DJ; Koshy M; Liptay MJ; Fidler MJ Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108 [TBL] [Abstract][Full Text] [Related]
6. Concurrent versus sequential chemoradiotherapy for unresectable locally advanced stage III non-small cell lung cancer: Retrospective analysis in a single United Kingdom cancer centre. Spencer A; Williams J; Samuel R; Boon IS; Clarke K; Jain P Cancer Treat Res Commun; 2021; 29():100460. PubMed ID: 34598059 [TBL] [Abstract][Full Text] [Related]
7. Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer. Ezer N; Smith CB; Galsky MD; Mhango G; Gu F; Gomez J; Strauss GM; Wisnivesky J Radiother Oncol; 2014 Aug; 112(2):272-8. PubMed ID: 25150635 [TBL] [Abstract][Full Text] [Related]
8. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342 [TBL] [Abstract][Full Text] [Related]
9. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients]. Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984 [TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy versus radiotherapy alone after induction chemoimmunotherapy for stage III NSCLC patients who did not undergo surgery: a single institution retrospective study. Guan S; Ren K; Zhang X; Yan M; Li X; Zhao L Radiat Oncol; 2023 Jul; 18(1):122. PubMed ID: 37491257 [TBL] [Abstract][Full Text] [Related]
11. Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer. Hung A; Lee KM; Lynch JA; Li Y; Poonnen P; Efimova OV; Hintze BJ; Buckingham T; Yong C; Seal B; Kelley MJ; Reed SD BMC Cancer; 2021 Jul; 21(1):824. PubMed ID: 34271861 [TBL] [Abstract][Full Text] [Related]
12. The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation. Dieleman E; van der Woude L; van Os R; van Bockel L; Coremans I; van Es C; De Jaeger K; Knol HP; Kolff W; Koppe F; Pomp J; Reymen B; Schinagl D; Spoelstra F; Tissing-Tan C; van der Voort van Zyp N; van der Wel A; Wijsman R; Dielwart M; Wiegman E; Damhuis R; Belderbos J Clin Lung Cancer; 2023 Mar; 24(2):130-136. PubMed ID: 36572596 [TBL] [Abstract][Full Text] [Related]
13. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial. Liang J; Bi N; Wu S; Chen M; Lv C; Zhao L; Shi A; Jiang W; Xu Y; Zhou Z; Wang W; Chen D; Hui Z; Lv J; Zhang H; Feng Q; Xiao Z; Wang X; Liu L; Zhang T; Du L; Chen W; Shyr Y; Yin W; Li J; He J; Wang L Ann Oncol; 2017 Apr; 28(4):777-783. PubMed ID: 28137739 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC. Qin A; Lusk E; Daignault-Newton S; Schneider BJ Clin Lung Cancer; 2019 Jul; 20(4):e495-e503. PubMed ID: 31088760 [TBL] [Abstract][Full Text] [Related]
15. Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center. Shrimali RK; Nallathambi C; Saha A; Das A; Prasath S; Mahata A; Arun B; Mallick I; Achari R; Dabkara D; Thambudorai R; Chatterjee S Indian J Cancer; 2018; 55(2):125-133. PubMed ID: 30604722 [TBL] [Abstract][Full Text] [Related]
16. Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer. Katsui K; Ogata T; Watanabe K; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S Acta Med Okayama; 2021 Jun; 75(3):269-277. PubMed ID: 34176930 [TBL] [Abstract][Full Text] [Related]
17. Sequential Versus Concurrent Chemoradiation Therapy by Surgical Margin Status in Resected Non-Small Cell Lung Cancer. Verma V; Moreno AC; Haque W; Fang P; Lin SH J Natl Compr Canc Netw; 2018 May; 16(5):508-516. PubMed ID: 29752325 [No Abstract] [Full Text] [Related]
18. Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status. Lee Y; Han JY; Moon SH; Nam BH; Lim KY; Lee GK; Kim HT; Yun T; An HJ; Lee JS Cancer Res Treat; 2017 Oct; 49(4):981-989. PubMed ID: 28111430 [TBL] [Abstract][Full Text] [Related]
19. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer. Sakin A; Sahin S; Atci MM; Sakin A; Yasar N; Geredeli C; Aksaray F; Cihan S Pulmonology; 2021; 27(1):26-34. PubMed ID: 31839507 [TBL] [Abstract][Full Text] [Related]
20. Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes. Dudani S; Zhu X; Yokom DW; Yamada A; Ho C; Pantarotto JR; Leighl NB; Zhang T; Wheatley-Price P Clin Lung Cancer; 2018 Jan; 19(1):e11-e18. PubMed ID: 28711384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]